17 September 2024 @ 10:26
Blog: Bioinformatics career story: Giulia Barbiera
Our project manager shares her career story
Our service is designed for scientists who want easy access to just the right kind of bioinformatics expertise. Watch the video to learn how it works.
Leave us a message to schedule a meeting with our expert and to receive a quotation.
You may alternatively send us an email at .
We analyze omics data from sequencing, array and mass-spec experiments
DNA sequencing enables identifying mutations, assembling genomes and studying genetic variation in populations of any species.
We analyze DNA sequence data from whole genomes, exomes, sequencing panels, SNP arrays and metagenomic experiments.
Transcriptome-wide expression analyses are the standard approach to study molecular mechanisms in biological systems from single cells to complex microbiomes.
We analyze data from bulk RNA-seq, single-cell RNA-seq, small RNA-seq and a range of other transcriptomic measurements.
Single-cell RNA sequencing enables cataloging cells at a scale and resolution unmatched by bulk sequencing.
We analyze single-cell RNA-seq data and integrate datasets across technology platforms, data types (including scATAC-seq), and species.
Spatial transcriptomics provides a molecular view of the organization of complex tissues.
We have experience in both developing new spatial transcriptomics technologies and applying them in various normal tissues and pathologies, such as tumors.
Epigenomics characterizes the chromatin state down to minuscule chemical modifications.
We analyze most types of epigenomic sequencing and array data to gain deeper understanding of gene regulation and to identify biomarkers for diseases.
Proteomics and metabolomics reveal the functional state of a biological system.
We perform pathway and biomarker analyses on protein and small molecule MS data.
Every time I spoke to Genevia, I had a lot of questions that needed clear and accurate answers. It was very satisfying to receive incredibly patient explanations. The communication was faultless! Essentially, the project was a common journey to evolving the data, with a lot of learning on both sides, as Genevia poured in their own ideas while accommodating inputs from our side.
I don't have to worry about bioinformatics, because I can leave that to professionals. at the same time, our scientists have learned a lot about bioinformatics and it's possibilities.
I was looking for a partner to validate and improve an algorithm that aims to identify the optimal combination of cancer therapy for each patient by assessing clinical data. The collaboration with Genevia’s team has gone without any challenges. Their response time is short, they are easy to communicate with and provide high-quality machine learning expertise.
Genevia’s bioinformaticians do not assume every biologist knows how to program. Instead, they were very generous in explaining their workflow and in educating us. With Genevia Technologies, I do not need to compromise my standards of communication, quality, or speed. I tried hard to think of any improvements for Genevia’s services, but I came out with none. That probably says it all.
We found ourselves in a real need to identify a bioinformatics partner, as experienced bioinformaticians are like gold dust. Since we started collaborating with Genevia, bioinformatics has no longer been a bottleneck, but the exact opposite. The Genevia team truly understands our research goals to the point where they are able to suggest the best analysis options tailored to our needs. The collaboration is working perfectly, we are genuinely satisfied with Genevia.
Our FastEV project seeks to develop and commercialize an innovative biomarker discovery platform based on extracellular vesicles. Genevia provided us with combinatorial analysis of multi-omics data, and we have already learned so much from the data in less than two months.
Genevia helped us to bring RNA-seq experiments in our R&D pipeline. By contracting this work, we were able to better focus our internal resources and still learn about sequencing and bioinformatics. We found that the Genevia team flexibly adapted to our requirements during the project.
Our own bioinformaticians had their hands full and considering the competitive nature of the field of genetics, I wanted to speed up the analysis process. Genevia delivered what they promised, and more – I was overwhelmed by the quality and usability of the project report. It is easy to call up Genevia when a sudden need for extra hands arises, or in-house knowledge needs replenishment. I can genuinely recommend them to everyone.
Genevia helped us validate the molecular characteristics of our cell lines. I found the communication between our respective field experts fluent. They are very flexible and professional, and their business is clearly driven by customer’s requirements.
We were in a need of a bioinformatics collaborator to advance the analysis of our cyanobacterial NGS data. Genevia Technologies provided us with flexible consulting on bioinformatics issues arising in our project. I appreciated the manner in which the project was executed, and would recommend Genevia to other academics.
We outsourced the bioinformatics component of our project to Genevia team, because we were not sure if we would benefit from recruiting a bioinformatician. I found that communication went smoothly, our collaboration was close and personal, and they adopted their analysis according to our needs.
I initially chose Genevia as my bioinformatics collaborator based on my colleague’s recommendation. Since then, we have worked on multiple projects together. I value their customer-centric service model, speed and most importantly, solid scientific competence of their data team.
I really appreciate the regular meetings and being kept up to date and having very easy access to everything, especially the descriptive reports. I also appreciate the project manager Maria Liivrand’s responsiveness and the clarity regarding schedules
Genevia goes beyond being a simple service provider, providing the scientific input that is comparable to a top academic collaboration.
Without the help of Genevia team I would not have been able to get my data analyzed at all. I found the collaboration professional, friendly and quite informative for me. Now I can more easily proceed to do further studies.
Learn more about our services and references by research area
Understand cancer, develop new drugs and personalize treatment with Genevia Technologies.
Our history in cancer bioinformatics is long: we have had the privilege to work with biologists seeking for a deeper understanding of cancer, companies developing new treatments to cancer, as well as oncologists wishing to optimize therapies to individual patients.
Research into the development, function and pathologies of the nervous system deserves the best bioinformatics support.
Whether you are tracking the development of the brain in mice, studying a neuropathology with iPSC-derived neurons or characterizing the microenvironment of CNS tumors, we ensure you get the most out of your ‘omics data.
Explore microbial functions, communities and interactions.
How does the genomic composition of microbes affect their functions and cross-species interactions? How can that information be used to discover new treatments or industrial applications?
Characterize cell types, immune repertoires and mechanisms of immune evasion at the highest resolution.
What are the key cell types that bring about an immune response? How do they develop? How do they malfunction in autoimmune diseases? And how can the immune system be leveraged to treat cancer?
Discover drug targets, mechanisms and biomarkers with cutting-edge omics data analysis.
Molecular measurements based on next-generation sequencing (NGS) and mass-spectrometry (MS) are routinely used throughout the drug development process.
17 September 2024 @ 10:26
Our project manager shares her career story
9 August 2024 @ 15:50
Our project manager shares his career story
8 November 2023 @ 13:00
Our project manager shares her career story
17 September 2023 @ 14:20
Learn how tumor DNA- and RNA-sequencing enables the discovery of target antigens and response markers for immunotherapies
4 November 2024 @ 11:36
Dr. Robert Hänsel-Hertsch, Group Leader at the Center for Molecular Medicine Cologne, shares his experiences with our Virtual Bioinformatics Core service
12 September 2024 @ 15:27
Dr. Melissa Vrohlings, Translational Science Leader of CDR-Life, shares her experiences with our Virtual Bioinformatics Core service
15 August 2024 @ 10:24
Dr. Vibhu Sahni shares his experiences with our Virtual Bioinformatics Core service
29 April 2024 @ 15:24
Dr. Henri Huttunen from Herantis Pharma shares his experiences with our Virtual Bioinformatics Core service
Describe your bioinformatics needs briefly to get things started.
You may alternatively send us an email at .